Mirtazapine modestly reduced methamphetamine use compared with placebo in a phase 3 randomized clinical trial in patients with moderate to severe methamphetamine use disorder, without improving depression, sleep, or quality of life.
Source: JAMA Psychiatry
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
